Anna Hurt

After completing my bachelor’s degree in Molecular Biotechnology at the FH Campus Vienna, I developed an interest in the underlying mechanisms of human diseases. This led me to join the Molecular Biology master’s program at the University of Vienna, with a major in Molecular Medicine. In 2022, I began working in Kaan Boztug’s lab for my master’s thesis, focusing on inborn errors of immunity, before joining the Precision Oncology Program in 2023. My main focus is the establishment of microscopy-based drug screening (Pharmacoscopy) for various pediatric cancers.